English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 853723      在线人数 : 1166
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版

    子类别

    期刊論文 [327/330]
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    邻近社群


    于重元 [19/19]
    劉柯俊 [85/98]
    劉滄梧 [119/125]
    劉界元(2003-2010) [3/3]
    夏和雄(1996-2012) [26/31]
    夏興國 [51/54]
    姜乃榕 [82/94]
    常慧如 [39/44]
    張俊彥 [234/254]
    張光裕 [69/79]
    張憶壽 [103/106]
    張文祥 [52/53]
    張書銘 [89/91]
    彭汪嘉康(1996-2007) [120/126]
    施能耀 [37/43]
    李家惠 [29/29]
    李岳倫 [48/49]
    林素芳 [32/32]
    楊奕馨 [41/42]
    江士昇 [88/90]
    沈哲宏 [14/16]
    洪文俊 [88/88]
    莊雙恩 [82/91]
    蔡坤志 [32/34]
    蔡慧珍 [66/71]
    蘇勇曄 [40/40]
    蘇振良 [24/25]
    郭靜娟 [71/76]
    陳尚鴻 [45/48]
    陳振陽 [72/72]
    陳美霞(2002-2009) [1/1]
    陳詩政 [2/2]
    陳雅雯 [38/39]
    黃智興 [55/55]
    黃道揚 [26/26]
    丁兆治(2000-2004) [5/5]
    其他 [464/471]
    劉敏(1996-2007) [60/62]
    劉玫英(2004-2006) [2/2]
    吳成文(1996-2008) [53/55]
    曾思文(1997-2007) [4/4]
    李冠德(1997-2004) [4/6]
    林景太(1999-2007) [5/5]
    楊文光(1996-1999) [21/21]
    王全正(1996-2003) [4/4]
    莊聲宏(1997-2004) [11/11]
    詹宗晃(2000-2008) [2/2]
    賴基銘(2004-2008) [41/47]
    阮麗蓉(2000-2006) [6/7]
    陳俊叡(2003-2007) [6/6]
    馬彥英(1997-1999) [1/1]
    黃奇英(2005-2007) [9/10]

    社群统计


    近3年内发表的文件:74(14.51%)
    含全文笔数:443(86.86%)

    文件下载次数统计
    下载大于0次:443(100.00%)
    下载大于100次:425(95.94%)
    全文下载总次数:177154(3.31%)

    最后更新时间: 2024-11-28 16:05

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目376-400 / 510. (共21页)
    << < 11 12 13 14 15 16 17 18 19 20 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2012-03 Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells Annals of Oncology. 2012 Mar;23(Suppl. 1):28.
    2012-02 Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825.
    2012-02 EGFR nuclear import in gallbladder carcinoma: Nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact Annals of Surgical Oncology. 2012 Feb;19(2):443-454.
    2012-02 Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy Journal of Clinical Oncology. 2012 Feb;30(4):613.
    2012-01 Long-term results of a randomized, observation-controlled, phase III trial of adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection Annals of Surgery. 2012 Jan;255(1):8-17.
    2011-12-15 Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors Free Radical Biology and Medicine. 2011 Dec 15;51(12):2195-2209.
    2011-12 Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study International Journal of Radiation Oncology, Biology, Physics. 2011 Dec;81(5):e749-e757.
    2011-12 t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement Cancer Chemotherapy and Pharmacology. 2011 Dec;68(6):1387-1395.
    2011-11 Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma Genes Chromosomes and Cancer. 2011 Nov;50(11):908-921.
    2011-11 Role of chromogranin a and neuron-specific enolase biomarkers in progression-free survival (PFS) with everolimus (EVE) versus placebo (PB) in patients with advanced pancreatic neuroendocrine tumors (pNET): Phase III radiant-3 results Neuroendocrinology. 2011 Nov;94(Suppl. 1):37.
    2011-10-01 Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036 Cancer Letters. 2011 Oct 1;309(1):110-118.
    2011-09 B cell-activating factor of TNF family (BAFF) signaling pathway is associated with Helicobacter Pylori-independent growth of gastric MALT lymphoma without T(11;18)(q21;q21) European Journal of Cancer. 2011 Sep;47(Suppl 1):S648-S649.
    2011-09 Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers European Journal of Cancer. 2011 Sep;47(Suppl 1):S467.
    2011-09 Nanovector-based therapies in advanced pancreatic cancer Journal of Gastrointestinal Oncology. 2011 Sep;2(3):185-194.
    2011-08-17 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289.
    2011-08 Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer Oncogene. 2011 Aug;30(33):3570-3584.
    2011-07 Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan Value in Health. 2011 Jul;14(5):647-651.
    2011-05 Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 European Journal of Cancer. 2011 May;47(8):1244-1257.
    2011-05 Novel Hsp90 inhibitor NVP-AUY922 downregulates mutant c-Kit protein through transcription and enhancing protein degradation via both proteasome and autophagy-mediated pathways Drug Metabolism Reviews. 2011 May;43(Suppl. 1):78-79.
    2011-04 Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas Cancer Research. 2011 Apr;71:Abstract number 1701.
    2011-03-07 2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors ChemMedChem. 2011 Mar 7;6(3):450-456.
    2011-02 Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications Laboratory Investigation. 2011 Feb;91:17A.
    2011-02 Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications Modern Pathology. 2011 Feb;24(Suppl. 1):17A-18A.
    2011-02 Effect of inhibition of heat-shock protein 90 on mutant c-Kit protein as modulated by mRNA expression and protein degradation through both proteasome and autophagy-mediated pathways Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4):Abstract Number 54
    2011-02 A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 237.

    显示项目376-400 / 510. (共21页)
    << < 11 12 13 14 15 16 17 18 19 20 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈